Proposed Data Collections Submitted for Public Comment and Recommendations, 26968-26969 [E6-7002]
Download as PDF
<![CDATA[
26968
Federal Register / Vol. 71, No. 89 / Tuesday, May 9, 2006 / Notices
Additionally, we are currently
accepting applications for FY2005 grant
cycle and will do so until July 31, 2006
or until all FY2005 funding has been
obligated. Please consult the FMCS Web
site (https://www.fmcs.gov) to download
forms and information.
1. J. Chester Porter, Shepherdsville,
Kentucky, and the William G. Porter
Revocable Trust, Sarasota, Florida; to
acquire voting shares of Porter Bancorp,
Inc., Shepherdsville, Kentucky, and
thereby indirectly acquire voting shares
of PBI Bank, Greensburg, Kentucky.
Fran Leonard,
Director, Budget and Finance, Federal
Mediation and Conciliation Service.
[FR Doc. E6–7034 Filed 5–8–06; 8:45 am]
Board of Governors of the Federal Reserve
System, May 4, 2006.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E6–6994 Filed 5–8–06; 8:45 am]
BILLING CODE 6732–01–P
BILLING CODE 6210–01–S
FEDERAL RESERVE SYSTEM
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisition of Shares of Bank or Bank
Holding Companies
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire a bank or bank
holding company. The factors that are
considered in acting on the notices are
set forth in paragraph 7 of the Act (12
U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the office of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than May 24,
2006.
A. Federal Reserve Bank of Atlanta
(Andre Anderson, Vice President) 1000
Peachtree Street, NE., Atlanta, Georgia
30309:
mstockstill on PROD1PC68 with NOTICES
1. Charles H. Roland and Kimberly O.
Roland, Andalusia, Alabama; to retain
voting shares of Southern National
Corporation, Andalusia, Alabama, and
thereby indirectly retain voting shares of
Covington County Bank, Andalusia,
Alabama.
B. Federal Reserve Bank of Chicago
(Patrick M. Wilder, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690-1414:
1. Harold Dean Westra, individually
and acting in concert with Greg Todd
Westra, both of Rock Valley, Iowa; to
acquire voting shares of Premier
Holdings, Ltd., Rock Valley, Iowa, and
thereby indirectly acquire voting shares
of Premier Bank, Rock Valley, Iowa.
C. Federal Reserve Bank of St. Louis
(Glenda Wilson, Community Affairs
Officer) 411 Locust Street, St. Louis,
Missouri 63166-2034:
VerDate Aug<31>2005
15:42 May 08, 2006
Jkt 208001
percent of the voting shares of Great
Florida Bank, Miami, Florida.
B. Federal Reserve Bank of Kansas
City (Donna J. Ward, Assistant Vice
President) 925 Grand Avenue, Kansas
City, Missouri 64198-0001:
1. BancFirst Corporation, Oklahoma
City, Oklahoma; to acquire 100 percent
of the voting shares of First Bartlesville
Bank, Bartlesville, Oklahoma.
Board of Governors of the Federal Reserve
System, May 4, 2006.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E6–6993 Filed 5–8–06; 8:45 am]
BILLING CODE 6210–01–S
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
Web site at https://www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than June 2, 2006.
A. Federal Reserve Bank of Atlanta
(Andre Anderson, Vice President) 1000
Peachtree Street, N.E., Atlanta, Georgia
30309:
1. Great Financial Corporation, Miami
Lakes, Florida; to become a bank
holding company by acquiring 100
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–06–0600]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Performance Evaluation Program for
Mycobacterium Tuberculosis and Non-
E:\FR\FM\09MYN1.SGM
09MYN1
Federal Register / Vol. 71, No. 89 / Tuesday, May 9, 2006 / Notices
Tuberculous Mycobacterium (NTM)
Drug Susceptibility Testing (0920–
0600)—Extension—National Center for
Health Marketing (NCHM), Coordinating
Center for Health Information and
Service (CoCHIS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
As part of the continuing effort to
support both domestic and global public
health objectives for treatment of
tuberculosis (TB), prevention of multidrug resistance and surveillance
programs, the Division of Laboratory
Systems seeks to continue to collect
information from domestic private
clinical and public health laboratories
twice per year. Participation and
information collections from
international laboratories are limited to
those which have public health
responsibilities for tuberculosis drug
susceptibility testing and approval by
26969
Information collected in this program
includes the susceptibility test results of
primary and secondary drugs,
concentrations, and test methods
performed by laboratories on a set of
challenge isolates sent twice yearly. A
portion of the response instrument
collects demographic data such as
laboratory type and the number of tests
performed annually. By providing an
evaluation program to assess the ability
of the laboratories to test for drug
resistant M. tuberculosis and selected
strains of NTM, laboratories have a selfassessment tool to aid in maximizing
their skills in susceptibility testing.
Information obtained from laboratories
on susceptibility testing practices and
procedures assists with determining
variables related to good performance,
with assessing areas for training and
with developing practice standards.
There are no cost to the respondents
other than their time.
their national tuberculosis program.
While the overall number of cases of TB
in the U.S. has decreased, rates still
remain high among foreign-born
persons, prisoners, homeless
populations, and individuals infected
with HIV in major metropolitan areas.
The rate of TB cases detected in foreignborn persons has been reported to be
almost nine times higher than the rate
among the U.S. born population.
CDC’s goal to eliminate TB will be
virtually impossible without
considerable effort in assisting countries
with heavy disease burden in the
reduction of tuberculosis. The
M.tuberculosis/NTM program supports
this role by monitoring the level of
performance and practices among
laboratories performing M. tuberculosis
susceptibility within the U.S, as well as
internationally, to ensure high-quality
laboratory testing, resulting in accurate
and reliable results.
ESTIMATED ANNUALIZED BURDEN HOURS
Respondents
No. of respondents
Average number of responses per
respondent
Average burden per response
(in hours)
Domestic Private/Public Laboratories ..............................................................
International Laboratories (with public health responsibilities) ........................
Total ..........................................................................................................
165
165
........................
1
1
........................
30/60
30/60
........................
Dated: May 1, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–7002 Filed 5–8–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–06–0469]
mstockstill on PROD1PC68 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
VerDate Aug<31>2005
15:42 May 08, 2006
Jkt 208001
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Program of Cancer
Registries—Cancer Surveillance
System—Extension (OMB number
0920–0469)—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Total burden
hours
83
83
166
Background and Brief Description
The American Cancer Society
estimated that about 1.37 million
Americans were newly diagnosed with
cancer in 2005 and that about 570,000
died from cancer in that same year. The
National Institutes of Health estimates
that in 2005, the cost of cancer was
about $209 billion, including $74 billion
direct costs to treat cancer, and $136
billion indirect costs in lost productivity
due to illness and premature death.
In 2002, CDC implemented the
National Program of Cancer Registries
(NPCR)—Cancer Surveillance System
(CSS) to collect, evaluate and
disseminate cancer incidence data
collected by population-based cancer
registries. In 2002, CDC began annually
publishing United States Cancer
Statistics (USCS). The latest USCS
report published in 2005 provided
cancer statistics for 93% of the United
States population from all cancer
registries whose data met national data
standards. Prior to the publication of
USCS, at the national level, cancer
incidence data were available for only
14% of the population of the United
States.
With this expanded coverage of the
U.S. population, it will now be possible
E:\FR\FM\09MYN1.SGM
09MYN1
]]>Agencies
[Federal Register Volume 71, Number 89 (Tuesday, May 9, 2006)]
[Notices]
[Pages 26968-26969]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7002]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-06-0600]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Performance Evaluation Program for Mycobacterium Tuberculosis and
Non-
[[Page 26969]]
Tuberculous Mycobacterium (NTM) Drug Susceptibility Testing (0920-
0600)--Extension--National Center for Health Marketing (NCHM),
Coordinating Center for Health Information and Service (CoCHIS),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
As part of the continuing effort to support both domestic and
global public health objectives for treatment of tuberculosis (TB),
prevention of multi-drug resistance and surveillance programs, the
Division of Laboratory Systems seeks to continue to collect information
from domestic private clinical and public health laboratories twice per
year. Participation and information collections from international
laboratories are limited to those which have public health
responsibilities for tuberculosis drug susceptibility testing and
approval by their national tuberculosis program. While the overall
number of cases of TB in the U.S. has decreased, rates still remain
high among foreign-born persons, prisoners, homeless populations, and
individuals infected with HIV in major metropolitan areas. The rate of
TB cases detected in foreign-born persons has been reported to be
almost nine times higher than the rate among the U.S. born population.
CDC's goal to eliminate TB will be virtually impossible without
considerable effort in assisting countries with heavy disease burden in
the reduction of tuberculosis. The M.tuberculosis/NTM program supports
this role by monitoring the level of performance and practices among
laboratories performing M. tuberculosis susceptibility within the U.S,
as well as internationally, to ensure high-quality laboratory testing,
resulting in accurate and reliable results.
Information collected in this program includes the susceptibility
test results of primary and secondary drugs, concentrations, and test
methods performed by laboratories on a set of challenge isolates sent
twice yearly. A portion of the response instrument collects demographic
data such as laboratory type and the number of tests performed
annually. By providing an evaluation program to assess the ability of
the laboratories to test for drug resistant M. tuberculosis and
selected strains of NTM, laboratories have a self-assessment tool to
aid in maximizing their skills in susceptibility testing. Information
obtained from laboratories on susceptibility testing practices and
procedures assists with determining variables related to good
performance, with assessing areas for training and with developing
practice standards.
There are no cost to the respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average number Average burden
Respondents No. of of responses per response Total burden
respondents per respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
Domestic Private/Public Laboratories............ 165 1 30/60 83
International Laboratories (with public health 165 1 30/60 83
responsibilities)..............................
Total....................................... .............. .............. .............. 166
----------------------------------------------------------------------------------------------------------------
Dated: May 1, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-7002 Filed 5-8-06; 8:45 am]
BILLING CODE 4163-18-P
